Sajkowski Daniel J sold $153K of CLMT

Sajkowski Daniel J sold 4,240 shares of Calumet, Inc. /DE (CLMT) at $36.16 ($0.15M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sajkowski Daniel J
Published Jul 2, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CLMT
Neutral
medium confidence
Mentioned
$CLMT
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLMTNeutralLow
01

Why it matters

The disclosure confirms an open-market sale by a director executed under a pre-arranged 10b5-1 plan; it does not provide new operating, financial, or regulatory information.

02

Market read

Traders may note the sale for sentiment monitoring, but it is unlikely to drive price without additional company-specific catalysts.

03

What to watch

Insider sales are common and often tax/portfolio-driven; without context on total insider activity or concurrent company news, signal quality is low.

Relevance 3/10Novelty 5/10Timing: Filed 2026-07-02; sale executed 2026-07-01.

Background

SEC Form 4 reports an insider transaction for Calumet, Inc. (CLMT).

Company-level read

Ticker impact

$CLMTNeutralMedium confidence
Context

Calumet, Inc. insider Daniel J. Sajkowski sold 4,240 shares on 2026-07-01 under a pre-arranged 10b5-1 plan for ~$153.3K.

Expected impact

Low near-term impact; any reaction is likely muted unless paired with other negative company news.

Evidence & confidence

The filing is a Form 4 sale (not a buy), but it specifies a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

None—single-company insider transaction with no sector-wide datapoint.

None.

None.

Counterpoint

A 10b5-1 sale can still coincide with insider expectations of near-term risk, but the plan structure usually limits the informational edge.

Key entities

  • Calumet, Inc.

    Subject of the Form 4 insider transaction; ticker CLMT.

  • Daniel J. Sajkowski

    Director who sold 4,240 shares on 2026-07-01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLMTHighAI 8/10

Calumet (CLMT) Q3 2026 Earnings Call Transcript

Calumet (CLMT) reported Q3 2026 earnings with adjusted EBITDA of $347.2M, up from $92.5M in Q3 2025. Net income was $273.3M, down from $313.4M YoY. The company retired $265M in debt, reducing annual interest by $26M. Specialty Products and Solutions EBITDA was $248.1M, while Montana Renewables EBITDA was $110.6M. Management highlighted debt reduction, strategic restructuring, and plans to increase sustainable aviation fuel production.

$CLMTMed

What Calumet (CLMT) Said on Its Q3 Earnings Call

Calumet (CLMT) reported Q3 earnings, highlighting a completed turnaround at its Shreveport facility and progress on Montana Renewables' expansion. Adjusted EBITDA for Montana Renewables was $110.6M, with CMR contributing $40.8M. The company plans to increase sustainable aviation fuel production, with a path to 200M gallons annually by 2028. Debt reduction remains a priority, with $175M in 2028 notes outstanding.

$CLMTHighAI 8/10

Calumet Reports Third Quarter 2026 Results

Calumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Calumet Reports Third Quarter 2026 Results • Third Quarter 2026 net income of $273.3 million, or basic earnings per common share of $2.91 • Third Quarter 2026 Adjusted EBITDA with Tax Attributes of $347.2 million • Accelerated deleveraging continues with approximatel